(3alpha,5alpha)-Androst-16-en-3-ol(CAS: 1153-51-1)

Regulatory guidelines for (3alpha,5alpha)-Androst-16-en-3-ol (CAS: 1153-51-1) include GHS classification, REACH regulations, and FDA/EPA requirements. Manufacturers and importers must ensure compliance with these standards for safety data sheets, labeling, and environmental protection.

There are several alternatives to (3alpha,5alpha)-Androst-16-en-3-ol in synthesis, including androst-4-en-3-one and androst-5-en-3-one. These reagents might be used as substitutes depending on the specific reaction conditions and desired product characteristics.

The market and research trends for (3alpha,5alpha)-Androst-16-en-3-ol (CAS: 1153-51-1) are focused on its use in hormone replacement therapy and as a precursor in steroid synthesis. Recent studies are exploring its potential in biochemistry and pharmacology, with an increasing emphasis on sustainable and environmentally friendly synthesis methods.

Waste containing (3alpha,5alpha)-Androst-16-en-3-ol (CAS: 1153-51-1) should be collected and disposed of in accordance with local regulations. Incineration or professional waste disposal services are recommended, ensuring proper handling to prevent environmental contamination and comply with safety standards.